Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2022.918868
Abstract: Carbapenems are commonly used to treat infections caused by multidrug-resistant (MDR) bacteria. Unfortunately, carbapenem resistance is increasingly reported in many gram-negative bacteria, especially Acinetobacter baumannii. Diazabicyclooctane (DBO) β-lactamase inhibitors, such as avibactam (AVI), when combined… read more here.
Keywords: sulbactam; zidebactam; combination; sulbactam susceptibility ... See more keywords